The Estée Lauder Companies Launches 2022 Breast Cancer Campaign to Honor 30th Anniversary and Positively Impact the Global Breast Cancer Community
30 Setembro 2022 - 7:45AM
Business Wire
The Estée Lauder Companies Charitable
Foundation will donate $15 million over five years to the Breast
Cancer Research Foundation to fund groundbreaking research
addressing breast cancer disparities
In the 30 years since Evelyn H. Lauder launched The Estée Lauder
Companies’ Breast Cancer Campaign (The Campaign) and co-created the
Pink Ribbon in 1992, The Campaign’s mission to help create a breast
cancer-free world for all has remained steadfast. The Estée Lauder
Companies (ELC) has a long-standing commitment to helping women and
girls achieve their highest potential. As ELC’s largest corporate
social impact program, The Campaign is a cornerstone of ELC’s
social investments in women’s advancement and health, uniting
people everywhere to positively impact the global breast cancer
community. As breast cancer is the most commonly diagnosed cancer
in the world,1 ELC's continued commitment to improving the lives of
all those touched by the disease remains unwavering.
This press release features multimedia. View
the full release here:
https://www.businesswire.com/news/home/20220930005040/en/
The Estée Lauder Companies Launches 2022
Breast Cancer Campaign (Graphic: Business Wire)
Together, The Estée Lauder Companies’ Breast Cancer Campaign and
The Estée Lauder Companies Charitable Foundation (ELCCF) have
funded more than $108 million globally for lifesaving research,
education and medical services, with more than $86 million funding
medical research grants through the Breast Cancer Research
Foundation (BCRF). Founded in 1993 by Evelyn H. Lauder, BCRF is
dedicated to advancing the world’s most promising research. ELC’s
commitment to breast cancer research, spanning three decades, has
been transformative. In partnership with BCRF, The Campaign has
helped fuel research across the entire spectrum of the disease—from
tumor biology, lifestyle and genetics, survivorship, treatment, and
metastasis—making an indelible mark in the diagnosis, care, and
prevention of breast cancer. In addition, The Campaign supports
more than 60 organizations worldwide, facilitating real change
aligned to the diverse needs of local communities.
Deaths from breast cancer have declined 42% in the U.S. since
the late 1980s.2 However, that progress has not been experienced
equally and certain populations are at higher risk for adverse
breast cancer outcomes. At every age, Black women in the U.S. are
more likely to die from breast cancer than any other race or ethnic
group, and mortality rates remain 41% higher than in white women,
despite lower incidence.3 The Campaign has and continues to support
BCRF-funded research that identifies and addresses disparities that
exist across the entire breast cancer landscape. ELCCF’s $15
million donation over five years will fund a new BCRF research
initiative to accelerate The Campaign’s goal of reducing breast
cancer disparities and improving outcomes. This comprehensive study
of the intersection of social determinants of health,
comorbidities, and the biology of breast cancer in Black women has
the potential to significantly impact breast cancer disparities
globally. It will help advance personalized breast cancer health
care across prevention, diagnosis, and treatment for those at most
risk of dying from the disease, and has the potential to be
groundbreaking for the global breast cancer community.
William P. Lauder, Executive Chairman of The Estée Lauder
Companies Inc. shared, “The potential impact that this BCRF
initiative will have in accelerating a crucial area of research
cannot be overstated, as we collectively work towards a more
equitable future for all. I know my mother, Evelyn Lauder, would be
so proud of the advancements we have made through research,
education, access to care and our commitment to help end breast
cancer.”
In the past 30 years globally, The Campaign has:
- Funded medical research and fellowships, as well as medical
resources, services and centers, including access to mammograms and
screenings for vulnerable groups with limited access to
healthcare.
- Advanced conversations on the importance of breast health
education and early detection by facilitating discussions between
the breast cancer community, medical experts and key opinion
leaders.
- Supported therapy and counseling programs to help improve the
lives of people with breast cancer and their families.
- Distributed educational materials and more than 180 million
Pink Ribbons to spread awareness.
“The Estée Lauder Companies’ success is deeply rooted in living
our shared values. Reflecting on the last 30 years, the incredible
progress made by The Breast Cancer Campaign has had a lasting
impact on our global community. As an authentic cornerstone of our
commitments, The Campaign has been supported by our employees,
consumers and partners worldwide. Today, it continues to inspire
action in people everywhere. As a Beauty Inspired, Values Driven
company, we look forward to the future and are committed to
advancing positive change for all of those touched by this
disease,” said Fabrizio Freda, President and Chief Executive
Officer, The Estée Lauder Companies Inc.
The Campaign will take the following actions aligned to its
mission for its 30th Anniversary:
- Double-down on The Campaign’s efforts to reduce breast cancer
disparities and improve health outcomes.
- Mobilize ELC’s passionate employees to unite in action and
support more than 60 organizations worldwide.
- Show support through 18 of ELC’s brands: Estée Lauder,
Clinique, Lab Series, Origins, La Mer, Bobbi Brown, Aveda, Jo
Malone London, Bumble and bumble, Darphin Paris, TOM FORD BEAUTY,
Smashbox, AERIN Beauty, Editions de Parfums Frédéric Malle,
GLAMGLOW, KILIAN PARIS, Too Faced, and Dr.Jart+. Each will donate
to BCRF and/or local cancer-focused organizations around the world,
with brand participation varying by market.
- Convene breast cancer thought leaders and advocates to advance
education and share important messages about the disease.
- Drive additional donations to BCRF through
ELCompanies.com/BreastCancerCampaign and various points of
engagement.
- Accelerate communications on social media including TikTok and
various Meta platforms to foster awareness, fundraising and
engagement, including new calls-to-action.
- Unveil a new series of global stories demonstrating the
diversity of the disease.
- Continue The Campaign’s tradition of illuminating buildings,
monuments and landmarks around the world in glowing pink lights to
raise awareness of breast health, including the Empire State
Building, New York City; the Eiffel Tower, Paris; LOTTE WORLD
TOWER, Seoul.
- Continue producing and distributing informative materials and
Pink Ribbons worldwide.
As long as breast cancer remains a life-threatening disease, The
Estée Lauder Companies’ commitment to the meaningful work that must
continue will not waiver. It’s #TimeToEndBreastCancer.
ABOUT THE ESTÉE LAUDER COMPANIES INC. The Estée Lauder
Companies Inc. is one of the world’s leading manufacturers,
marketers, and sellers of quality skin care, makeup, fragrance, and
hair care products. The company’s products are sold in
approximately 150 countries and territories under brand names
including: Estée Lauder, Aramis, Clinique, Lab Series, Origins,
M·A·C, La Mer, Bobbi Brown, Aveda, Jo Malone London, Bumble and
bumble, Darphin Paris, TOM FORD BEAUTY, Smashbox, AERIN Beauty, Le
Labo, Editions de Parfums Frédéric Malle, GLAMGLOW, KILIAN PARIS,
Too Faced, Dr.Jart+, and the DECIEM family of brands, including The
Ordinary and NIOD.
ELC-C ELC-I
_____________________________ 1 World Health Organization 2
American Cancer Society® Facts and Figures 2021-2022 3 American
Cancer Society® Key Statistics for Breast Cancer
View source
version on businesswire.com: https://www.businesswire.com/news/home/20220930005040/en/
Erin Cohen The Estée Lauder Companies ercohen@estee.com
Estee Lauder Companies (NYSE:EL)
Gráfico Histórico do Ativo
De Mar 2024 até Abr 2024
Estee Lauder Companies (NYSE:EL)
Gráfico Histórico do Ativo
De Abr 2023 até Abr 2024